152 related articles for article (PubMed ID: 11697623)
1. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease.
Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
Leuk Lymphoma; 2001; 42(5):1055-65. PubMed ID: 11697623
[TBL] [Abstract][Full Text] [Related]
2. T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects.
Axdorph U; Porwit-Macdonald A; Sjøberg J; Grimfors G; Bjørkholm M
APMIS; 2002 May; 110(5):379-90. PubMed ID: 12076255
[TBL] [Abstract][Full Text] [Related]
3. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte populations in lymph nodes in different histological types of Hodgkin's disease in children.
Pituch-Noworolska A; Drabik G; Kacińska E; Klekawka T
Acta Haematol; 2004; 112(3):129-35. PubMed ID: 15345894
[TBL] [Abstract][Full Text] [Related]
5. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen.
Papadimitriou CS; Bai MK; Kotsianti AJ; Costopoulos JS; Hytiroglou P
Leuk Lymphoma; 1995 Dec; 20(1-2):125-30. PubMed ID: 8750633
[TBL] [Abstract][Full Text] [Related]
6. Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease.
Ben-Ezra J; Sheibani K; Swartz W; Stroup R; Traweek ST; Kezirian J; Rappaport H
Hum Pathol; 1989 Dec; 20(12):1181-5. PubMed ID: 2591947
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
Audouin J; Diebold J; Pallesen G
J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
11. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
[TBL] [Abstract][Full Text] [Related]
12. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
[TBL] [Abstract][Full Text] [Related]
13. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis.
Sandvej KB; Hamilton-Dutoit SJ; Pallesen G
Leuk Lymphoma; 1993 Jan; 9(1-2):95-101. PubMed ID: 7682882
[TBL] [Abstract][Full Text] [Related]
14. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
15. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
16. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease.
Samoszuk M; Ramzi E
Leuk Lymphoma; 1993 Mar; 9(4-5):315-9. PubMed ID: 8348067
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
20. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia.
Teruya-Feldstein J; Jaffe ES; Burd PR; Kingma DW; Setsuda JE; Tosato G
Blood; 1999 Apr; 93(8):2463-70. PubMed ID: 10194423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
